ApTOLL: A new therapeutic aptamer for cytoprotection and (re)myelination after multiple sclerosis.
Fernández-Gómez B, Marchena MA, Piñeiro D, Gómez-Martín P, Sánchez E, Laó Y, Valencia G, Nocera S, Benítez-Fernández R, Castaño-León AM, Lagares A, Hernández-Jiménez M, de Castro F.
Fernández-Gómez B, et al. Among authors: lao y.
Br J Pharmacol. 2024 May 14. doi: 10.1111/bph.16399. Online ahead of print.
Br J Pharmacol. 2024.
PMID: 38742374